ARHGAP19 Antikörper
-
- Target Alle ARHGAP19 Antikörper anzeigen
- ARHGAP19 (rho GTPase Activating Protein 19 (ARHGAP19))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ARHGAP19 Antikörper ist unkonjugiert
-
Applikation
- Immunocytochemistry (ICC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Recombinant protein encompassing a sequence within the center region of human ARHGAP19. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product ARHGAP19 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- ARHGAP19 (rho GTPase Activating Protein 19 (ARHGAP19))
- Andere Bezeichnung
- Rho GTPase activating protein 19 (ARHGAP19 Produkte)
- Hintergrund
- Rho GTPase activating protein 19,Members of the ARHGAP family, such as ARHGAP19, encode negative regulators of Rho GTPases (see RHOA, MIM 165390), which are involved in cell migration, proliferation, and differentiation, actin remodeling, and G1 cell cycle progression (Lv et al., 2007 [PubMed 17454002]).[supplied by OMIM]
- Molekulargewicht
- 56 kDa
- Gen-ID
- 84986
- UniProt
- Q14CB8
-